Doctor profile · Federal record

Dr. Robert Lagrone, MD

Rheumatology Physician (CMS: Rheumatology) · Nashville, TN

  • NPI 1417903378
  • Accepts Medicare
  • MIPS 98.8 / 100 · 2023
  • 39 yrs in practice
  • Male
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
2001 Charlotte Ave, Suite #102
Nashville, TN 372032032
(615) 321-3277

Credentials & registration

NPPES · NUCC
NPI registered
May 2006 — 20 yrs on file
Profile last updated
April 20, 2010
Year of graduation
1987 — 39 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Tennessee #MD20971

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1417903378. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
186,806
Distinct HCPCS
10
Medicare allowed
$2,268,441
HCPCS Description Services Patients Avg allowed
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 103,600 30 $5
J3262 Injection, tocilizumab, 1 mg 42,231 12 $6
J1745 Injection, infliximab, excludes biosimilar, 10 mg 30,533 66 $33
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 5,625 14 $42
J0897 Injection, denosumab, 1 mg 1,320 13 $23
96413 Administration of chemotherapy into vein, 1 hour or less 705 107 $116
J7050 Infusion, normal saline solution, 250 cc 701 107 $1
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 582 46 $65
99214 Established patient office or other outpatient visit, 30-39 minutes 499 303 $116
96415 Administration of chemotherapy into vein, each additional hour 466 71 $26

In context: peer comparison

Among 19 peers in Nashville Rheumatology Physician, average services per provider: 2,153. This provider delivers 87× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,413
Transactions
141
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Amgen INC. 25 $363.40
Abbvie INC. 27 $351.53
Novartis Pharmaceuticals Corporation 23 $318.61
Ucb, INC. 20 $265.11
AstraZeneca Pharmaceuticals Lp 7 $232.11
Janssen Biotech, INC. 9 $205.73
Fresenius Kabi USA, LLC 9 $201.03
Pfizer INC. 5 $107.02
Lilly USA, LLC 4 $104.28
Boehringer Ingelheim Pharmaceuticals, INC. 3 $57.99
Sandoz INC. 3 $53.39
Sobi, INC 2 $42.31
Organon LLC 2 $39.14
Ultragenyx Pharmaceutical INC. 1 $28.51
E.R. Squibb & Sons, L.L.C. 1 $26.02

By nature of payment

Food and Beverage
$2,368
Education
$45

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
4,083
Patients
1,197
Total drug cost
$1,431,034
Drug Type Claims Patients Total cost
Prednisone Generic 888 360 $14,325
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 587 75 $18,659
Methotrexate (Methotrexate Sodium) Brand 395 133 $17,642
Duloxetine Hcl Generic 329 106 $10,313
Tramadol Hcl Generic 286 53 $3,456
Trazodone Hcl Generic 267 81 $6,814
Hydroxychloroquine Sulfate Generic 257 81 $18,779
Gabapentin Generic 246 50 $4,890
Tizanidine Hcl Generic 241 98 $5,515
Leflunomide Generic 139 47 $13,824

Frequently asked questions

Auto-generated from federal data
What is Dr. Robert Lagrone's medical specialty?
Dr. Robert Lagrone practices Rheumatology Physician in Nashville, TN.
Where does Dr. Robert Lagrone practice?
Dr. Robert Lagrone practices at 2001 Charlotte Ave, Nashville, TN 372032032. Office phone: 6153213277.
What is Dr. Robert Lagrone's NPI?
Dr. Robert Lagrone's National Provider Identifier (NPI) is 1417903378, issued by NPPES.
Does Dr. Robert Lagrone accept Medicare assignment?
Yes. Dr. Robert Lagrone accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Robert Lagrone commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745). Source: CMS Medicare Physician & Other Practitioners file.